{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:37:19Z","timestamp":1791916639037,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/eye.2013.5","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T10:55:01Z","timestamp":1362135301000},"page":"657-662","source":"Crossref","is-referenced-by-count":58,"title":["Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting"],"prefix":"10.1038","volume":"27","author":[{"given":"S","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T R","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"BFeye20135_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1126\/science.257.5073.1055","volume":"257","author":"BR Bloom","year":"1992","unstructured":"Bloom BR, Murray CJ . Tuberculosis: commentary on a reemergent killer. Science 1992; 257: 1055\u20131064.","journal-title":"Science"},{"key":"BFeye20135_CR2","first-page":"121","volume":"52","author":"R Singh","year":"2004","unstructured":"Singh R, Gupta V, Gupta A . Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol 2004; 52: 121\u2013125.","journal-title":"Indian J Ophthalmol"},{"key":"BFeye20135_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ajo.2008.06.011","volume":"146","author":"R Bansal","year":"2008","unstructured":"Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK . Role of anti-tubercular therapy in uveitis with latent\/manifest tuberculosis. Am J Ophthalmol 2008; 146: 772\u2013779.","journal-title":"Am J Ophthalmol"},{"key":"BFeye20135_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ajo.2009.11.020","volume":"149","author":"A Gupta","year":"2010","unstructured":"Gupta A, Bansal R, Gupta V, Sharma A, Bambery P . Ocular signs predictive of tubercular uveitis. Am J Ophthalmol 2010; 149: 562\u2013570.","journal-title":"Am J Ophthalmol"},{"key":"BFeye20135_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ajo.2011.05.004","volume":"152","author":"V Gupta","year":"2011","unstructured":"Gupta V, Bansal R, Gupta A . Continued progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment. Am J Ophthalmol 2011; 152: 857\u2013863.","journal-title":"Am J Ophthalmol"},{"key":"BFeye20135_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT . Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005; 140: 509\u2013516.","journal-title":"Am J Ophthalmol"},{"key":"BFeye20135_CR7","first-page":"1","volume":"49","author":"Centers for Disease Control","year":"2000","unstructured":"Centers for Disease Control. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep 2000; 49: 1\u201354.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"BFeye20135_CR8","unstructured":"World Health Organization. Treatment of Tuberculosis: Guidelines 4th edn World Health Organization: Geneva, Switzerland, 2010 pp 95."},{"key":"BFeye20135_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/09273948.2010.525680","volume":"19","author":"SK Ganesh","year":"2011","unstructured":"Ganesh SK, Roopleen, Biswas J, Veena N . Role of high-resolution computerized tomography (HRCT) of the chest in granulomatous uveitis: a tertiary uveitis clinic experience from India. Ocul Immunol Inflamm 2011; 19: 51\u201357.","journal-title":"Ocul Immunol Inflamm"},{"key":"BFeye20135_CR10","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/clinids\/19.6.1092","volume":"19","author":"B Afghani","year":"1994","unstructured":"Afghani B, Lieberman JM . Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994; 19: 1092\u20131099.","journal-title":"Clin Infect Dis"},{"key":"BFeye20135_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.eye.6702662","volume":"21","author":"SR Rathinam","year":"2007","unstructured":"Rathinam SR, Lalitha P . Paradoxical worsening of ocular tuberculosis in HIV patients after anti-retroviral therapy. Eye 2007; 21: 667\u2013668.","journal-title":"Eye"},{"key":"BFeye20135_CR12","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/eye.2008.204","volume":"23","author":"CM Cheung","year":"2009","unstructured":"Cheung CM, Chee SP . Jarisch-Herxheimer reaction: paradoxical worsening of tuberculosis chorioretinitis following initiation of antituberculous therapy. Eye 2009; 23: 1472\u20131473.","journal-title":"Eye"},{"key":"BFeye20135_CR13","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/eye.2010.110","volume":"24","author":"S Basu","year":"2010","unstructured":"Basu S, Das T . Pitfalls in the management of TB-associated uveitis. Eye 2010; 24: 1681\u20131684.","journal-title":"Eye"},{"key":"BFeye20135_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/bmj.286.6369.923","volume":"286","author":"WA McAllister","year":"1983","unstructured":"McAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ . Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983; 286: 923\u2013925.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"BFeye20135_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12348-011-0020-3","volume":"1","author":"S Parchand","year":"2011","unstructured":"Parchand S, Tandan M, Gupta V, Gupta A . Intermediate uveitis in the Indian population. J Ophthalmic Inflamm Infect 2011; 1: 65\u201370.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"BFeye20135_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjophthalmol-2011-300209","volume":"96","author":"M Ang","year":"2012","unstructured":"Ang M, Hedayatfar A, Wong W, Chee SP . Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study. Br J Ophthalmol 2012; 96: 332\u2013336.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"BFeye20135_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ajo.2011.02.006","volume":"152","author":"R Gineys","year":"2011","unstructured":"Gineys R, Bodaghi B, Carcelain G, Cassoux N, Boutin le TH, Amoura Z et al. QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis related ocular inflammation. Am J Ophthalmol 2011; 152 (3): 433\u2013440.e1.","journal-title":"Am J Ophthalmol"},{"key":"BFeye20135_CR18","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/605559","volume":"49","author":"HM Peto","year":"2009","unstructured":"Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR . Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009; 49: 1350\u20131357.","journal-title":"Clin Infect Dis"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye20135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye20135","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye20135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:21:11Z","timestamp":1684430471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye20135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFeye20135"],"URL":"https:\/\/doi.org\/10.1038\/eye.2013.5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}